Lunai Bioworks Inc.
LNAI
$0.56
$0.34162.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -59.43% | -54.53% | -19.96% | -44.79% | 20.37% |
| Depreciation & Amortization | -64.80% | 28.09% | 4.82% | 5.61% | -3.31% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -59.89% | -56.74% | -24.71% | -52.54% | 6.47% |
| Operating Income | 59.89% | 56.74% | 24.71% | 52.54% | -6.47% |
| Income Before Tax | 75.19% | 106.38% | -705.59% | 100.32% | -60.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 75.19% | 106.38% | -705.59% | 100.32% | -60.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 75.19% | 106.38% | -705.59% | 100.32% | -60.13% |
| EBIT | 59.89% | 56.74% | 24.71% | 52.54% | -6.47% |
| EBITDA | 59.86% | 57.22% | 24.88% | 52.74% | -6.54% |
| EPS Basic | 82.91% | 104.53% | -589.73% | 100.22% | 34.84% |
| Normalized Basic EPS | 71.35% | 68.83% | 48.57% | 67.79% | 58.11% |
| EPS Diluted | 82.91% | 104.53% | -584.62% | 100.21% | 34.84% |
| Normalized Diluted EPS | 71.35% | 68.83% | 48.57% | 68.10% | 58.11% |
| Average Basic Shares Outstanding | 45.11% | 40.76% | 16.80% | 48.59% | 145.74% |
| Average Diluted Shares Outstanding | 45.11% | 40.76% | 16.80% | 50.05% | 145.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |